We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $109B Turnover 32.07%
1-Year Est. Return 29.28%
 

Walleye Capital is a multi-strategy hedge fund firm that grew out of an options market making business. It was set up in 2005 by Irvin Kessler, who had earlier founded Deephaven Capital Management, and Pete Goddard, along with three others, and it began taking outside money and became a hedge fund in 2017. Its strategies fall into four groups: fundamental equities, quant, volatility and tactical, with volatility trading, the original options market making, one of the longest running. Its Quantic unit runs systematic, model-driven strategies across equities, futures and options, and in 2023 the firm launched Dockside Platforms, which connects investors with smaller money managers. Walleye stopped accepting money from new investors in July 2025.

This Fund
S&P 500
This Quarter Est. Return
+0.44%
1 Year Est. Return
+29.28%
3 Year Est. Return
+134.68%
5 Year Est. Return
+196.78%
10 Year Est. Return
–
AUM
$109B
AUM Growth
+$80.6B
Cap. Flow
+$3.22B
Cap. Flow %
2.96%
Top 10 Hldgs %
16.04%
Holding
6,304
New
1,631
Increased
3,208
Reduced
922
Closed
391
Avg Time Held Equity + Options
1.4 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$646M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$449M
3
NVDA icon
NVIDIA
NVDA
+$424M
4
TSM icon
TSMC
TSM
+$334M
5
AVGO icon
Broadcom
AVGO
+$333M

Sector Composition

Rank Sector Weight
1 Miscellaneous 81.57%
2 Technology 5.53%
3 Consumer Discretionary 2.34%
4 Financials 2.3%
5 Industrials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VKTX icon
1301
PUT
Viking Therapeutics
VKTX
$3.42B
$9.18M 0.01%
281,500
+264,000
+1,509% +$9.14M
2023 Q4
11 quarters
BIIB icon
1302
PUT
Biogen
BIIB
$37.2B
$9.15M 0.01%
40,500
+28,000
+224% +$5.94M
2022 Q4
15 quarters
CAH icon
1303
Cardinal Health
CAH
$65.6B
$9.15M 0.01%
41,108
+40,841
+15,296% +$9.5M
2025 Q2
5 quarters
FAST icon
1304
PUT
Fastenal
FAST
$63.2B
$9.14M 0.01%
184,600
+99,900
+118% +$4.89M
2023 Q1
14 quarters
ATLC icon
1305
Atlanticus Holdings
ATLC
$1.28B
$9.13M 0.01%
104,330
+102,300
+5,039% +$9.9M
2026 Q2
1 quarter
TMO icon
1306
PUT
Thermo Fisher Scientific
TMO
$256B
$9.11M 0.01%
13,500
+4,200
+45% +$2.5M
2022 Q3
16 quarters
AMKR icon
1307
Amkor Technology
AMKR
$8.44B
$9.1M 0.01%
173,770
+107,719
+163% +$6M
2026 Q2
1 quarter
ESS icon
1308
Essex Property Trust
ESS
$17.6B
$9.1M 0.01%
+33,774
New +$9.6M
2026 Q3
0 quarters
AS icon
1309
CALL
Amer Sports
AS
$16.9B
$9.1M 0.01%
333,300
+300,200
+907% +$9.6M
2025 Q1
6 quarters
SNY icon
1310
PUT
Sanofi
SNY
$116B
$9.09M 0.01%
220,500
+169,000
+328% +$7.35M
2023 Q1
14 quarters
DUOL icon
1311
CALL
Duolingo
DUOL
$7.96B
$9.09M 0.01%
63,800
+56,600
+786% +$7.85M
2023 Q1
14 quarters
CAMT icon
1312
Camtek
CAMT
$4.36B
$9.04M 0.01%
58,260
+57,011
+4,565% +$8.38M
2026 Q2
1 quarter
UMC icon
1313
CALL
United Microelectronic
UMC
$36B
$9.01M 0.01%
368,000
+237,000
+181% +$5.07M
2025 Q3
4 quarters
MKSI icon
1314
MKS
MKSI
$13.8B
$9M 0.01%
33,920
+6,304
+23% +$1.86M
2024 Q2
9 quarters
GRPN icon
1315
CALL
Groupon
GRPN
$496M
$9M 0.01%
455,400
+410,900
+923% +$9.34M
2024 Q4
7 quarters
ENTG icon
1316
CALL
Entegris
ENTG
$21.4B
$9M 0.01%
58,400
+57,700
+8,243% +$8.12M
2023 Q1
14 quarters
CVE icon
1317
CALL
Cenovus Energy
CVE
$51B
$8.99M 0.01%
289,300
+93,800
+48% +$2.83M
2023 Q2
13 quarters
IP icon
1318
PUT
International Paper
IP
$17.6B
$8.98M 0.01%
270,700
+179,300
+196% +$6.86M
2022 Q4
15 quarters
GFS icon
1319
GlobalFoundries
GFS
$22B
$8.96M 0.01%
186,980
-43,168
-19% -$2.25M
2023 Q3
12 quarters
WBD icon
1320
DELISTED
Warner Bros
WBD
$8.96M 0.01%
289,438
-63,974
-18% -$1.77M
2023 Q4
11 quarters
T icon
1321
CALL
AT&T
T
$151B
$8.95M 0.01%
367,000
-96,000
-21% -$2.32M
2022 Q3
16 quarters
CELH icon
1322
CALL
Celsius Holdings
CELH
$7.91B
$8.95M 0.01%
327,100
+254,300
+349% +$7.55M
2022 Q3
16 quarters
VKTX icon
1323
Viking Therapeutics
VKTX
$3.42B
$8.94M 0.01%
274,173
+262,871
+2,326% +$9.11M
2024 Q1
10 quarters
ALGN icon
1324
PUT
Align Technology
ALGN
$11.9B
$8.92M 0.01%
61,400
+58,300
+1,881% +$9.6M
2022 Q3
16 quarters
BN icon
1325
CALL
Brookfield
BN
$90.2B
$8.92M 0.01%
+244,600
New +$10.1M
2026 Q3
0 quarters

Similar funds

Walleye Capital's Q3 2026 Portfolio in Review

As of Q3 2026, Walleye Capital held 6,304 positions worth $109B, up 288% from $28B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Walleye Capital's Q3 2026 filing shows 1,631 new, 3,208 increased, 922 reduced and 391 closed positions. Its largest new stake was State Street Technology Select Sector SPDR ETF: 518,129 shares worth $101M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.41B.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Walleye Capital's largest Q3 2026 buy was State Street Technology Select Sector SPDR ETF: 518,129 shares worth $101M.
  • Walleye Capital added most to Intel in Q3 2026, an estimated $646M increase.
  • Walleye Capital's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.41B.
  • Walleye Capital fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2026, selling an estimated $1.8B.
  • Walleye Capital's ten largest holdings make up 16% of its $109B portfolio in Q3 2026.
  • Walleye Capital opened 1,631 new positions and closed 391 in Q3 2026.
  • Walleye Capital's portfolio value rose 288% quarter-over-quarter to $109B.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.